首页 | 本学科首页   官方微博 | 高级检索  
检索        

大剂量丙种球蛋白冲击疗法对急性重症病毒性肺炎的近期疗效分析
引用本文:刘艳秀,赖永艺,瞿长春,汪利华,梁永强.大剂量丙种球蛋白冲击疗法对急性重症病毒性肺炎的近期疗效分析[J].国际医药卫生导报,2012,18(10):1455-1457.
作者姓名:刘艳秀  赖永艺  瞿长春  汪利华  梁永强
作者单位:1. 527300,云浮市人民医院呼吸内科
2. 527300,云浮市人民医院儿科
摘    要:目的 研究使用大剂量丙种球蛋白冲击疗法治疗急性重症病毒性肺炎的疗效与副作用.方法 我院收治的103例急性重症病毒性肺炎患者随机分为治疗组52例和对照组51例,治疗组患儿大剂量丙神球蛋白冲击治疗.结果 治疗组康复速度大于对照组,且无任何副作用.各项免疫抗体如IgG、IgA、IgM等均较治疗前有一定程度增高.结论 大剂量丙种球蛋白冲击疗法能促进病毒性肺炎的康复,提高患者的免疫功能并缩短病程,具有良好的治疗效果和安全性.

关 键 词:丙种球蛋白  重症肺炎  病毒

Analysis on curative effect of large doses of gamma globulin pulse therapy treatment to severe acute viral pneumonia
LIU Yan-xiu , LAI Yong-zhi , ZHAI Chang-chun , WANG Li-hua , LIANG Yong-qiang.Analysis on curative effect of large doses of gamma globulin pulse therapy treatment to severe acute viral pneumonia[J].International Medicine & Health Guidance News,2012,18(10):1455-1457.
Authors:LIU Yan-xiu  LAI Yong-zhi  ZHAI Chang-chun  WANG Li-hua  LIANG Yong-qiang
Institution:.Respiratory Medicine Department, The People's HospitM of Yunfu, Yunfu 527300, China
Abstract:Objective To investigate the efficacy and side effects of large doses of gamma globulin pulse therapy treatment to severe acute viral pneumonia treatment. Methods In our hospital, 103 cases of severe acute viral pneumonia patients were randomly divided into two groups: 52 cases in group A as the treatment group; 51 cases in group B, as the control group. Treatment group was given high-dose gamma globulin impact treatment. Results The rehabilitation speed of the treatment group after treatment was much faster than that of the control group, without any side effects. Various immune functions, such as the IgG, IgA and IgM were increased somehow than before treatment. Conclusion The impact of high- dose gamma globulin therapy will promote the rehabilitation of viral pneumonia and the patients' immune function, with recent and excellent therapeutic efficacy and safety.
Keywords:Gamma globulin  Severe pneumonia  Virus
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号